ALEXANDRIA, Va., Sept. 23 -- United States Patent no. 12,421,269, issued on Sept. 23, was assigned to CGeneTech (Suzhou China) Co. Ltd. (Jiangsu, China).
"SGLT2/DPP4 inhibitor and application thereof" was invented by Qinghua Mao (Shanghai), Tao Yu (Shanghai), Lu Gan (Shanghai), Yi Li (Shanghai), Chengde Wu (Shanghai) and Shuhui Chen (Shanghai).
According to the abstract* released by the U.S. Patent & Trademark Office: "Compounds as SGLT2/DPP4 dual inhibitors, and application in preparation of medicines as the SGLT2/DPP4 dual inhibitors. A compound represented by formula (I), and an isomer or pharmaceutically acceptable salt thereof are specifically involved."
The patent was filed on July 24, 2020, under Application No. 17/629,527.
*For ...